New Specialty Pharmacy Medical Step Therapy Requirements (Healthy Blue + Medicare (HMO D-SNP))

April 14, 2023
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Pharmacy
media-label
label
link
Pharmacy
icon-position
right
full-width
false
full-width-mobile
false
button-type
lh-button
variant
text
text
Blue Medicare
media-label
label
link
Blue Medicare
icon-position
right
full-width
false
full-width-mobile
false

Please note, this communication applies to Healthy Blue + Medicare℠ (HMOD-SNP) offered by Blue Cross and Blue Shield of North Carolina.

Effective June 1, 2023, the following Part B medications from the current Clinical Criteria guidelines will be included in our medical step therapy precertification review process. Step therapy review will apply upon precertification initiation in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below.

Clinical Criteria guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria.

Clinical UM Guidelines Preferred drug(s) Nonpreferred drug(s)
CC-1017 (PDF) Avastin
Mvasi
Alymsys
Vegzelma
Zirabev

For more information, visit Healthy Blue + Medicare.

Blue Cross and Blue Shield of North Carolina Senior Health, DBA Blue Cross and Blue Shield of North Carolina, is an HMO D-SNP plan with a Medicare contract and a NC State Medicaid Agency Contract (SMAC). Enrollment in Blue Cross and Blue Shield of North Carolina Senior Health depends upon contract renewal

NCBCBS-CR-022279-23-CPN22010 April 2023